Successful investing requires a delicate balance between risk tolerance and a profound understanding of ever-changing market dynamics.
Entering the world of sub-penny stocks, we’ll be exploring four intriguing OTC stocks that have recently shown momentum. By examining these stocks, investors can gain valuable insights into emerging opportunities within the sub-penny landscape.
Epazz Inc. (OTC:EPAZ) is a multi-faceted, innovative company involved with providing drone technology, cloud-based business software solutions, and blockchain mobile applications.
On September 7, the company announced that it had made a significant presentation to the United States Department of Homeland Security. The company made the presentation after the agency expressed its interest in deploying the company’s drones in its pilot programs.
The potential collaboration could prove to be a significant leap for Epazz, given that it could open up the lucrative world of partnerships and contracts with government agencies. In recent times, Epazz has been working on procuring the requisite licenses and certifications that would be necessary to become a defense contractor.
CEO Shaun Passley, PhD, said, “The demand for ZenaDrone 1000 is high among US government agencies. We will be providing a made-in-America drone that carries a heavy payload at an affordable price.”
However, that is not all. The company noted at the time that it had been working on a number of demonstrations of its product, the ZenaDrone 1000. Epazz is also involved in active discussions with the United States Navy, the United States Army, and the United States Air Force pertaining to potential deals for the ZenaDrone 1000. That was also a reflection of the potential demand for the product.
ZenaDrone is an American-made drone that has been designed by Epazz to carry heavy payloads. The company made it available at a competitive price point as well. Epazz also offers a pilot program that would allow a pilot customer to use the drone for a period of 90 days. The Chief Executive Officer of the company, Shaun Passley, noted that the demand for ZenaDrone 1000 was high among government agencies in the United States.
On August 31, Epazz made an announcement pertaining to its pilot program for Zenadrone and also mapped out its roadmap for the next nine months. The company revealed that in the third fiscal quarter of 2023, it was going to work on continuing to sign up government and military security agencies, boost production of the ZenaDrone 1000, begin the process for the joint venture in South Africa, and conclude the joint venture in Brazil.
Shaun Passley, Ph.D., CEO of Epazz Inc., said, “We are excited about the next nine months; our marketing efforts are working, and we are turning meetings into demos, and finally we are getting close to the next level.”
The company provided its plans up until the first quarter of 2023. Epazz also revealed that it was on course to generate revenues from its drone as a service business by the end of 2023. It was further noted at the time that it had been working toward this end for the past four years.
The worldwide drone market has garnered considerable attention and has been growing at a compound annual growth rate (CAGR) of 30%. By 2028, the market is expected to be worth more than $190 billion, and Epazz is one of the many companies that are working on grabbing a piece of that pie.
BioAdaptives Inc. (OTC: BDPT) is involved in the manufacturing and distribution of plant- and algae-based products that boost the health and wellness of animals as well as humans. The products from BioAdaptives Inc. are particularly focused on defense of the immune system, pain relief, resistance to stress, recovery from injury, anti-aging, and anti-viral activity.
On September 8, the company announced that it had decided to spin off its LiveStock Impact Division into a fully owned subsidiary unit. LiveStock Impact Inc., the new company, would be involved in working on other programs and partnerships while continuing with the work of developing and marketing natural supplements. The supplements are meant to boost the performance of pets and other animals. Additionally, the subsidiary would also work on expanding its business worldwide through the supply of veterinary supplements.
BioAdaptives also announced the names of those who had been appointed as directors and members of the management at LiveStock Impact. Edward Jacobs, who is the Managing Director, Chief Executive Officer, and Director of BioAdaptives, had been appointed chairman of the board; Robert Ellis, a Director and President of BioAdaptives, was made President and Director; and the Chief Operating Officer of BioAdaptives, Robert Ellis, was appointed as the director and chief operating officer of the subsidiary.
The president of LiveStock Impact, Robert Ellis, spoke about the development as well. He noted that the spin-off transaction had taken place at the best possible time since the management anticipated that there was going to be rapid growth in the worldwide animal products sales space. He went on to add that the company was reacting to a significant new demand from veterinary patients for competitively priced new supplement formulas.
SOHM Inc. (OTC: SHMN) is an emerging generic pharmaceutical manufacturing and marketing firm. SHMN is involved in the nutraceutical, cosmetic, and pharmaceutical spaces. SOHM Inc. manufactures and also markets generic drugs that cover a range of treatments.
On September 11, the company was in the news after it announced that it had appointed a new Vice President of Quality in the form of Wm. Dewey Rushing. The Chief Executive Officer and President of the company, Baron Night, spoke about the appointment as well. He noted that Rushing had served the company as a member of the Advisory Board since 2022. On the basis of his experience in leadership and management, Rushing decided to accept the full-time role that he had been offered.
Night went on to add that Rushing had been an experienced remediation and quality professional who had worked for more than three decades in the quality assurance space. Rushing also works in the area of cGMP compliance for products regulated by the US Food and Drug Administration. Since joining the Advisory Board of the company, Rushing has been providing the company with his expertise in the areas of compliance and validation. Due to his exceptional experience and qualifications, the company had decided to appoint him in the role, Night added.
In the news release, SOHM noted Rushing held a BA degree in biology and a BS in microbiology from Kansas State University. Additionally, he had also been awarded a Master of Science degree from San Diego State University in pharmaceutical regulatory affairs. In a statement, Rushing stated that he was thrilled at the prospect of working with the leadership and management at SOHM. He went on to note that he had also enjoyed his role as a member of the advisory board and would be intent on taking the company to new levels.
Metatron Apps Inc. (OTC:MRNJ) is one of the better-known mobile app development companies, known for its record of having developed over 2000 apps. Some of the apps developed by Metatron Apps Inc. have also been ranked in the top 20 in the app stores. On September 11, the company announced that it had entered into a partnership with HempCoin THC Blockchain, a major innovator in the world of blockchain-powered cryptocurrencies.
The two companies announced that they were going to enter into a path-breaking joint venture that would be focused on the creation of a leading-edge mobile game. The game is aimed at redefining the gaming experience for players across the world. The merger would focus on combining the strengths of both companies and developing a game inspired by the hugely popular game Farmville. The companies, on the other hand, would add their own spin to the game.
The game would provide players with the experience of establishing and managing their own cannabis dispensary. The eventual aim of the game would be to build a massive cannabis company. In order to generate revenues from the game, Metatron Apps would put in place monetization strategies like promotions from cannabis brands and other related advertisements.
The players would also be provided with the option of subscription payments, which would unlock premium features and provide a much better gaming experience. The game also seeks to provide a unique experience through the introduction of AI non-playable characters (AI NPCs). The characters would have unique personalities and also have memories from previous interactions with the players. This feature would enable players to interact with suppliers, regulators, and customers within the game and create long-term relationships. The company believes that AI NPCs will have a significant impact on player progress in the game.
Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) is owned by RazorPitch Inc. and has been retained by Epazz Inc. to assist in the production and distribution of content. ‘CGR’ is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport/RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR/RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Please visit CapitalGainsReport.com/Disclaimer for full disclaimer.